GSM城市站国家站国际

联合干预后血液β淀粉样蛋白42上升约35%:《自然·通讯》论文称舌下硝酸甘油加全身振动与脑源蛋白外排相关,29名健康成年人受试

2026-11-08 · 科技 · GSM News
联合干预后血液β淀粉样蛋白42上升约35%:《自然·通讯》论文称舌下硝酸甘油加全身振动与脑源蛋白外排相关,29名健康成年人受试

《自然·通讯》11月3日发表 Tuunanen 等作者的论文《血管机械治疗与人类脑蛋白外排增加相关》。这是一项在健康志愿者中进行的随机交叉试验:共29名健康成年人(其中女性15名,平均年龄44岁,年龄范围27至61岁)参加,接受两种干预,针对 Piezo1 机械敏感通道的全身振动(WBVp,27人)与一氧化氮介导血管舒张联合全身振动(NO+WBVp,26人);另有12人参加了仅一氧化氮干预的探索性环节。研究团队来自芬兰奥卢大学等机构,试验注册号为 EudraCT 2021-000625-27。

主要结果方面,联合干预后,受试者血液中低分子量(小于68 kDa)脑源蛋白显著上升:血清β淀粉样蛋白40由干预前38.2 pg/ml升至校正后50.5 pg/ml,β淀粉样蛋白42由2.6 pg/ml升至3.5 pg/ml(升幅约35%),胶质纤维酸性蛋白(GFAP)中位数由65.2 pg/ml升至85.1 pg/ml;而分子量更大的神经丝轻链与磷酸化 tau-181 未见变化,作者据此提出分子大小可能是脑脊液向血液转运蛋白的一个因素。干预期间受试者血压下降,收缩压平均下降14.9%、舒张压平均下降14.8%;血压下降幅度与三种蛋白的升幅相关。磁共振方面,联合干预后全脑 T2 黑液(T2DF)信号强度平均下降4.6%,脑外游离脑脊液体积平均增加6.5 ml。

作者口径方面,论文标题与结论均使用「相关」(associated with)表述:该研究测量的是血液生物标志物与影像指标的变化,未测量脑内淀粉样蛋白负荷或认知结果;小鼠鞘内示踪实验为人体观察提供生物学支持。论文为正式发表的同行评审论文,上述数值均为该单次干预试验的实测结果,不构成任何治疗建议。

(来源:《自然·通讯》)

Blood Amyloid-Beta 42 Rose About 35% After a Single Combined Session: A Nature Communications Paper Links Sublingual Nitroglycerin Plus Whole-Body Vibration to Brain Protein Efflux in 29 Healthy Adults

A paper published in Nature Communications on November 3 by Tuunanen and colleagues, titled "Vasomechanic treatment is associated with increased efflux of human brain proteins," reports a randomized crossover trial in healthy volunteers. Twenty-nine healthy adults (15 female; mean age 44 years, range 27-61) took part, undergoing mechanotransductive whole-body vibration targeting the Piezo1 channel (WBVp, n = 27) and the combined protocol of nitric-oxide-mediated vasodilation with WBVp (NO+WBVp, n = 26), with an additional exploratory NO-only session in a subset (n = 12). The team is led from the University of Oulu in Finland, and the trial registration is EudraCT 2021-000625-27.

After the combined intervention, low-molecular-weight (under 68 kDa) brain-derived proteins in blood rose significantly: serum amyloid-beta 40 from 38.2 pg/ml before treatment to a hemodilution-corrected 50.5 pg/ml after, amyloid-beta 42 from 2.6 to 3.5 pg/ml (a rise of about 35%), and glial fibrillary acidic protein (GFAP) from a median of 65.2 to 85.1 pg/ml. The larger neurofilament-light and phosphorylated tau-181 proteins were unaltered, which the authors say suggests molecular weight could be a factor in CNS-to-blood protein movement. Systolic and diastolic blood pressure fell during the intervention by means of 14.9% and 14.8% respectively, and the extent of blood-pressure reduction correlated with the increases in all three proteins. On MRI, whole-brain T2 dark-fluid signal intensity decreased by a mean of 4.6% after the combined treatment, and segmented extracerebral free CSF volume increased by a mean of 6.5 ml.

The paper's title and conclusions use the language of association: the study measured changes in blood biomarkers and imaging signals, and did not measure brain amyloid burden or cognition; complementary intrathecal tracer studies in mice provided biological support. The article is a formally published, peer-reviewed paper; the figures are single-session trial measurements and amount to no treatment recommendation.

(Source: Nature Communications)

来源:《自然·通讯》

发布:GSM·美国(发布链接)

图片来源:图:志愿者接受 PiB PET 扫描以检测脑内淀粉样蛋白(资料图)。CSIRO 摄,CC BY 3.0,经 Wikimedia Commons。 / Photo: A volunteer receiving a PiB PET scan to detect brain amyloid (file photo). Photo by CSIRO, CC BY 3.0, via Wikimedia Commons.

GSM Global · 本篇英文版 English edition of this story

本频道最新更多 ›

← 返回科技 全部新闻 关于我们

GSM首页白宫联邦加州南加各州社会军事司法选举世界中国城市站国家站移民宣传专题视频直播放映厅电子书科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构